Press

News Release Archive

2010
11/3/2010IntelligentMDx Awarded Approximately $1,032,000 of Nontaxable Grants for Qualifying Therapeutic Discovery Projects
3/24/2010IntelligentMDx (IMDx) Receives FDA Emergency Use Authorization (EUA) for First 2009 H1N1 Influenza Assay to be Authorized for Use on Multiple Instruments in Commercial Laboratories
1/2/2010IMDx Announces Issuance of a Key European Personalized Medicine Patent Directed to Methods for Symptom-Based Disease Diagnosis
2009
12/21/2009IntelligentMDx received certification to the ISO 13485:2003 Quality Management Systems standards and guidelines
12/17/2009Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics
11/29/2009IMDx Announces Issuance of a Key U.S. Personalized Medicine Patent Directed to Methods for Determining Suitability of Therapeutic Agents
11/11/2009Jerome “Jerry” Kenney,” Senior Advisor to Blackrock and Former Vice Chairman of Merrill Lynch, Joins IntelligentMDx’s Board of Directors
11/2/2009Alice Jacobs, MD, founder, chair, and CEO of IntelligentMDx, talks with IVD Technology about trends and technological developments in MDx
10/3/2009Dr. Phillip Moen Named Director, Product Development at IntelligentMDx
9/22/2009Dr. Alice Jacobs describes new influenza test on Fox Business News
8/19/2009IntelligentMDx Produces Novel Flu Assay
7/28/2009IMDx Announces Issuance of a Key U.S. Personalized Medicine Patent Directed to Symptom-Based Diagnostic Tests
7/21/2009IntelligentMDx to Provide Analytical and Verification Services to a Major Academic Institution
7/3/2009IntelligentMDx featured on CNBC Healthy Horizons
6/17/2009IntelligentMDx appoints Richard Whitley, M.D. as an advisor
5/1/2009IntelligentMDx Completes Major Expansion at Cambridge Research Facility
4/13/2009IntelligentMDx to attend and present at 25th Annual Clinical Virology Conference
2/2/2009Sarah S. Toomey, Esq. Named Director, Intellectual Property at IntelligentMDx
1/26/2009Alice Jacobs, IntelligentMDx’s CEO, Attends the 2009 World Economic Forum in Davos, Switzerland
1/8/2009Verification Studies of IntelligentMDx’s Proprietary Molecular Diagnostic Assay Process Have Been Completed
2008
11/12/2008IMDx Announces Issuance in Japan of a Key Personalized Medicine Patent Directed to Methods for Symptom-Based Diagnosis
10/29/2008Poster Presented at the Annual Association for Molecular Pathology Meeting (AMP)
10/28/2008Battelle to Perform Verification Studies of IntelligentMDx’s Proprietary Molecular Diagnostic Assay Process
6/3/2008IntelligentMDx to Present Poster at American Society for Microbiology Regarding its HSV PCR Reagents
6/1/2008Poster Presented at the American Society of Microbiology
4/26/2008Poster Presentation to be made at Clinical Virology Symposium Detailing Results of IntelligentMDx’s HSV Real-Time PCR Reagents
4/11/2008IntelligentMDx Moves to New Corporate Headquarters and Custom Lab Facility